TD Cowen lowered the firm’s price target on Qiagen (QGEN) to $48 from $50 and keeps a Hold rating on the shares. The firm updated its model as its Q3 report reflected solid trends while the Q4 and 2026 outlook were drags.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QGEN:
- Qiagen’s Hold Rating: Solid Q3 Performance Overshadowed by Uncertainties and Mixed Growth Outlook
- Qiagen’s Hold Rating: Navigating Market Crosswinds and Valuation Concerns
- Qiagen price target lowered to $46 from $49 at Baird
- QIAGEN Announces Q3 Results, Parse Acquisition, and Share Repurchase
- Qiagen Reports Strong Asset Growth in Q3 2025